(Reuters) -Medical technology firm Heartflow said on Thursday it has raised $316.7 million in its U.S. initial public offering.
The Mountain View, California-based company priced 16.67 million shares at $19 each, compared with its targeted range of $17 and $18 apiece.
U.S. IPOs have picked up pace in a much-awaited recovery, as solid tech earnings and progress on trade deals have helped restore investor confidence.
Strong recent debuts mark a reversal from early April, when uncertainty around U.S. President Donald Trump’s tariffs paused dealmaking.
Heartflow’s stock will begin trading on the Nasdaq on Friday under the “HTFL” ticker symbol. The closing of the offering is expected on August 11.
J.P. Morgan, Morgan Stanley and Piper Sandler are the lead underwriters for the offering.
(Reporting by Ateev Bhandari, Pritam Biswas and Surbhi Misra in Bengaluru; Editing by Alan Barona)
About the Author
